Tobam Eli Lilly & CO Transaction History

Tobam

$1.12 Billion
Q1 2024

A detailed history of Tobam transactions in Eli Lilly & CO stock. As of the latest transaction made, Tobam holds 43,604 shares of LLY stock, worth $39.5 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares

43,604

Previous 56,906 23.38%

Holding current value

$39.5 Million

Previous $33.2 Million 2.26%

% of portfolio

3.04%

Previous 2.9%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $7.88 Million - $10.5 Million	-13,302 Reduced 23.38%	43,604 $33.9 Million
Q4 2023 Jan 26, 2024	SELL	$525.19 - $619.13 $858,685 - $1.01 Million	-1,635 Reduced 2.79%	56,906 $33.2 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $7.95 Million - $11 Million	18,294 Added 45.45%	58,541 $31.4 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $8.71 Million - $11.6 Million	-24,839 Reduced 38.16%	40,247 $18.9 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $5.7 Million - $6.7 Million	-18,359 Reduced 22.0%	65,086 $22.4 Million

Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $2.78 Million - $3.24 Million	-8,654 Reduced 9.4%	83,445 $30.5 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $5.5 Million - $6.27 Million	-18,551 Reduced 16.77%	92,099 $29.8 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $20.5 Million - $24.1 Million	-73,636 Reduced 39.96%	110,650 $35.9 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $5.8 Million - $7.21 Million	-24,715 Reduced 11.83%	184,286 $52.8 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $6.18 Million - $7.66 Million	-27,467 Reduced 11.62%	209,001 $57.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $4.24 Million - $5.21 Million	19,116 Added 8.79%	236,468 $54.6 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $20.6 Million - $26.7 Million	114,334 Added 110.98%	217,352 $49.9 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $16.4 Million - $21.3 Million	99,981 Added 3292.1%	103,018 $19.2 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $18,394 - $24,340	141 Added 4.87%	3,037 $513,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $423,453 - $489,800	2,896 New	2,896 $429,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $753,189 - $819,276	-7,053 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $106,469 - $124,276	961 Added 15.77%	7,053 $781,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.19 Million - $1.4 Million	-10,651 Reduced 63.61%	6,092 $790,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $1.77 Million - $1.99 Million	16,743 New	16,743 $1.94 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $2.49 Million - $2.86 Million	-32,945 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $94,988 - $112,128	1,280 Added 4.04%	32,945 $2.55 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $275,564 - $295,574	3,363 Added 11.88%	31,665 $2.67 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $813,396 - $902,789	10,554 Added 59.47%	28,302 $2.42 Million
Q2 2017 Aug 08, 2017	BUY	N/A	17,748	17,748 $1.46 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account